Preparation of chiral pyrrolidinone derivatives
AssigneeZeneca Limited
InventorsGlynn Mitchell, Shaheen Khatoon Vohra
Life of this patent
Estimating the term…
Loading patent…
AssigneeZeneca Limited
InventorsGlynn Mitchell, Shaheen Khatoon Vohra
Estimating the term…
A process for preparing a compound of formula IIa or IIb: ##STR1## wherein R.sup.2, R.sup.3, R.sup.4 and R.sup.5 independently represent hydrogen or C.sub.1 -C.sub.4 alkyl; and A is an optionally substituted aromatic or heteroaromatic ring system; the process comprising the steps of: (a) reacting a racemic mixture of a compound of formula II: ##STR2## wherein R.sup.2, R.sup.3, R.sup.4, R.sup.5 and A are as defined for formulae IIa and IIb; with a sterically hindered chiral esterifying agent to form enantiomers of formulae IIIa and IIIb: ##STR3## wherein R.sup.2, R.sup.3, R.sup.4, R.sup.5 and A are as defined for formulae IIa and IIb and R.sup.15 is a chiral sterically hindered residue; b) separating the diastereoisomers of formulae IIIa and IIIb; and (c) converting the diastereoisomers of formulae IIIa and IIIb separately to compounds of formulae IIa and IIb respectively by acid or base hydrolysis. If required, the unwanted enantiomer of formula IIa or IIb may be inverted to give the preferred isomer.
A process for the preparation of a compound of formula IIa or IIb:
A process for the preparation of a compound of formula IIa or IIb:
A process for preparing a compound of formula II so as to obtain an enantiomeric excess of a compound of formula IIa or IIb:
Dependencies are inferred from the claim text.